Growing community of inventors

Milan, Italy

Orietta Veneroni

Average Co-Inventor Count = 5.22

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Orietta VeneroniPatricia Salvati (4 patents)Orietta VeneroniLuca Benatti (3 patents)Orietta VeneroniRoberto Maj (2 patents)Orietta VeneroniRuggero Fariello (2 patents)Orietta VeneroniRoberto Pellicciari (1 patent)Orietta VeneroniPiero Melloni (1 patent)Orietta VeneroniFlorian Thaler (1 patent)Orietta VeneroniElena Barbanti (1 patent)Orietta VeneroniLuciano Dho (1 patent)Orietta VeneroniMarcello Calabresi (1 patent)Orietta VeneroniFariello Ruggero (0 patent)Orietta VeneroniRoberto Maj (1 patent)Orietta VeneroniFariello Ruggero (1 patent)Orietta VeneroniOrietta Veneroni (4 patents)Patricia SalvatiPatricia Salvati (47 patents)Luca BenattiLuca Benatti (12 patents)Roberto MajRoberto Maj (10 patents)Ruggero FarielloRuggero Fariello (9 patents)Roberto PellicciariRoberto Pellicciari (66 patents)Piero MelloniPiero Melloni (47 patents)Florian ThalerFlorian Thaler (15 patents)Elena BarbantiElena Barbanti (9 patents)Luciano DhoLuciano Dho (2 patents)Marcello CalabresiMarcello Calabresi (1 patent)Fariello RuggeroFariello Ruggero (0 patent)Roberto MajRoberto Maj (2 patents)Fariello RuggeroFariello Ruggero (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Newron Pharmaceuticals S.p.a. (4 from 40 patents)


4 patents:

1. 8710040 - Pharmaceutical composition comprising gabapentin or an analogue thereof and an α-aminoamide and its analgesic use

2. 8084447 - Pharmaceutical composition comprising gabapentin or an analogue thereof and an α-aminoamide and its analgesic use

3. 7718815 - Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders

4. 7709523 - Alpha-aminoamide derivatives useful as antimigraine agents

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/4/2026
Loading…